How a Golden Ticket Could Transform Medicine Forever
Remember that feeling each time a character in a movie, a play or a book is presented with a golden ticket - or its symbolic equivalent? Yeah, me too. Well, Lambda pulled a real-life version of that, and the winner? A biotech squad named Synlico. Their prize? Six months of free, full-time access to an NVIDIA GH200 Grace Hopper Superchip GPU (96GB of VRAM!).
Their mission? Crack the code on diseases like cancer by understanding the true cause-and-effect relationships behind gene interactions.
Meet Synlico: The Decoder of Cell Causality
Founded in 2021, Synlico is the pilot of cell biology—instead of flying blind, it navigates the causal pathways of gene interactions to steer drug development in the right direction. How? By combining AI with causal discovery to move beyond correlations and pinpoint the true cause-and-effect relationships in biology, making cellular processes explainable, predictable, and engineerable.
“We focus on developing innovative therapies for oncology and other diseases by leveraging advanced AI technologies” said Jingwei Lu, Founder and CEO of Synlico.
“By including causal discovery & inference, deep generative models, and single-cell bioinformatics, we unravel the causal relationships between genetic modulation of cells and their responses in the patients’ heterogeneous microenvironment.”
Synlico’s been using Lambda since 2023, where they found cost-efficient and flexible solutions for all their AI model training: “Lambda has been instrumental in accelerating our research and reducing the computational bottlenecks associated with handling large-scale AI models and patients' single cell data.”
And that GH200 GPU instance they won? It will allow Synlico to conduct testing for their causal model faster and more cost-effectively, especially on workflows that require constant interaction between CPU and GPU.
2025 is Synlico’s Year
With AI-driven therapies and personalized medicine becoming a reality (CRISPR!), Synlico's timing is great. They released their large-scale single cell transcriptomics database with 57 million cells and 12,000 patient samples, and are on track to release an expanded version with around 100 million cells and over 20,000 patient samples: simply one of the largest human scRNA-seq databases in the world!
Who knows what other great things the next Lambda Golden Ticket might just bring?
Want to follow their journey? Here’s Synlico on LinkedIn: https://www.linkedin.com/company/synlico-inc/
Curious about NVIDIA GH200? Check this blog post that puts the GPU to the test with Llama 3.3 70B and enjoy an aggressive price to get into the ARMs race!